Late thrombus formation (3.8 × 2.4 cm) occurred in a patient post-LAAO with minimal peri-device leak, resolved after 2 months of warfarin therapy.
Does high-intensity warfarin therapy resolve late massive device-related thrombus in a patient with prior LAAO and minimal peri-device leak?
Even minimal peri-device leak can serve as a nidus for significant late thrombus formation after LAAO, which can be successfully treated with high-intensity warfarin therapy.
Absolute Event Rate: 0% vs 0%
Rationale: Stroke prevention in patients with non-valvular atrial fibrillation who cannot tolerate long-term anticoagulation remains a major clinical challenge. Left atrial appendage occlusion (LAAO) offers an alternative strategy to reduce thromboembolic risk, but device-related thrombus (DRT) formation can undermine its protective benefit. Although most DRT occur early, late thrombus formation related to minimal peri-device leak (PDL) is increasingly recognized. Understanding this rare but serious complication is crucial for optimizing long-term post-LAAO management. Patient concerns: A 65-year-old male with prior ischemic stroke presented to the emergency department 10 months after LAAO with acute dizziness but no neurological deficits. Diagnoses: Transesophageal echocardiography and cardiac computed tomography angiography revealed a large thrombus (3.8 × 2.4 cm) on the Watchman device with minimal PDL, consistent with massive late DRT. Interventions: The patient was started on high-intensity warfarin therapy (international normalized ratio: 2.5–3.5) for anticoagulation. Clopidogrel was temporarily discontinued to reduce bleeding risk. Outcomes: After 2 months of warfarin therapy, repeat cardiac imaging confirmed complete thrombus resolution. The patient remained neurologically intact without embolic complications. Lessons: Even minimal PDL can serve as a nidus for significant late thrombus formation, particularly in patients with interrupted anticoagulation. This case highlights the importance of continued long-term imaging surveillance after LAAO and individualized anticoagulation strategies. Clinicians should maintain vigilance for late DRT, especially in high-risk patients, and consider extended follow-up protocols to optimize outcomes.
Chen et al. (Fri,) reported a other. Late thrombus formation (3.8 × 2.4 cm) occurred in a patient post-LAAO with minimal peri-device leak, resolved after 2 months of warfarin therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: